Impact of expert review on 5021 referral nondefinitive diagnoses according to sampling procedures
| Diagnostic changes . | CNB (n = 1898) . | Surgical excision (n = 3123) . | P . |
|---|---|---|---|
| Changes to definite diagnoses (n = 4460) | 1545 (81.4%) | 2915 (93.3%) | <.00001 |
| Unclassified lymphoma to classified lymphoma | 925 (48.7%) | 1707 (54.7%) | |
| Unclassified lymphoma to nonlymphoid neoplasm or reactive lesion | 29 (1.5%) | 91 (2.9%) | |
| Uncertain to lymphoma | 418 (22.0%) | 635 (20.3%) | |
| Uncertain to nonlymphoid neoplasm or reactive lesion | 173 (9.1%) | 482 (15.4%) | |
| No changes (n = 561) | 353 (18.6%) | 208 (6.7%) | <.00001 |
| Diagnostic changes . | CNB (n = 1898) . | Surgical excision (n = 3123) . | P . |
|---|---|---|---|
| Changes to definite diagnoses (n = 4460) | 1545 (81.4%) | 2915 (93.3%) | <.00001 |
| Unclassified lymphoma to classified lymphoma | 925 (48.7%) | 1707 (54.7%) | |
| Unclassified lymphoma to nonlymphoid neoplasm or reactive lesion | 29 (1.5%) | 91 (2.9%) | |
| Uncertain to lymphoma | 418 (22.0%) | 635 (20.3%) | |
| Uncertain to nonlymphoid neoplasm or reactive lesion | 173 (9.1%) | 482 (15.4%) | |
| No changes (n = 561) | 353 (18.6%) | 208 (6.7%) | <.00001 |